PVALB and amyotrophic lateral sclerosis: As previously shown by immunoblotting and proteomics in the WR and SOD mouse models of ALS [39,40], respectively, the concentration of the cytosolic Ca2+-binding protein parvalbumin is drastically lowered in motor neuron disease.